Based on our CENTRAL hypothesis of using an aromatase inhibitor for induction of ovulation (as explained above), the success of an aromatase inhibitor in inducing ovulation in patients with PCOS was reported [417-420]. The gene discussed is CYP19A1; the disease is polycystic ovary syndrome.